Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.
about
Management of Viral Central Nervous System Infections: A Primer for CliniciansNeonatal Herpes Simplex Viral Infections and Acyclovir: An Update.Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.Antiviral drug resistance as an adaptive processChemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis.MYC-induced reprogramming of glutamine catabolism supports optimal virus replication.Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase InhibitorsPronounced Inhibition Shift from HIV Reverse Transcriptase to Herpetic DNA Polymerases by Increasing the Flexibility of α-Carboxy Nucleoside Phosphonates.A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1Multicenter Evaluation of Meridian Bioscience HSV 1&2 Molecular Assay for Detection of Herpes Simplex Virus 1 and 2 from Clinical Cutaneous and Mucocutaneous Specimens.Helicase-primase as a target of new therapies for herpes simplex virus infections.Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.Visualization of DNA G-quadruplexes in herpes simplex virus 1-infected cells.Cell entry mechanisms of HSV: what we have learned in recent years.Anti-herpes simplex virus 1 and immunomodulatory activities of a poly-γ- glutamic acid from Bacillus horneckiae strain APA of shallow vent origin.Antibacterial, antifungal, and antiviral effects of three essential oil blends.Antiviral Activity of Myticin C Peptide from Mussel: an Ancient Defense against Herpesviruses.Anti-HSV-1 and HSV-2 Flavonoids and a New Kaempferol Triglycoside from the Medicinal Plant Kalanchoe daigremontiana.Anti-herpes simplex virus activity of polysaccharides from Eucheuma gelatinae.A G4·K(+) hydrogel that self-destructs.Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitisResveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview
P2860
Q30145523-F3FD86A4-9323-4AAE-B89A-97C174AFF006Q30234575-69F22A16-4858-4A7F-AFD0-A8E01828F849Q33815823-77148CA9-0404-4283-88FF-9D32B5B9ADDEQ33878407-2D8792D9-6F22-4557-A688-99568B55105DQ36287725-FD47FE5E-9216-4D7D-BED0-00F2BC299830Q36320460-F17F4332-3B1D-4A5B-AB05-788EC6DE4B9BQ36760555-9EBD4AD8-25DD-4E1B-8EEA-1A4002C29216Q36970906-862A57DA-87E3-4CC0-95C7-4ACB49A47806Q37059841-F50033A7-4128-4EB9-BC45-54C38C2D7F36Q37132010-37857EC7-9FB9-4734-AE2C-BAA4E70B2AC5Q38351481-5313D55D-8727-4ED8-8B31-05925AE284DDQ38613285-F404EA14-B9D3-47AD-BC4B-E66BACD4B6BDQ38735386-EB448734-3E32-41F5-93F9-3FA17E37A7A8Q38882932-0DA3007E-D985-4065-A537-1299C907C44BQ40054372-2C6D01B7-C13C-4D35-A217-3D13B8CF672FQ40291293-34906D5E-B331-499D-BD25-32278482EB6DQ40698840-FC54E1FE-CD3D-440B-A49D-8132458E5B08Q41364781-3A1BFF94-42E3-4F79-90AD-94AEB26214ADQ41532519-252CFB4B-3BBF-484F-BD88-B860D85EEE73Q53167068-332D1B54-E47C-406E-AA0D-C209C1F5AB9BQ58597250-CE6B31AE-5E24-4B0C-BEE6-46CF2E2A3940Q58766430-DF9899D7-7E2E-48DE-B353-D950B0D0924D
P2860
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current and future therapies f ...... of action and drug resistance.
@en
type
label
Current and future therapies f ...... of action and drug resistance.
@en
prefLabel
Current and future therapies f ...... of action and drug resistance.
@en
P1476
Current and future therapies f ...... of action and drug resistance
@en
P2093
Scott H James
P356
10.1016/J.COVIRO.2014.06.003
P577
2014-07-16T00:00:00Z